You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Proteomic study of plaque fluid in high caries and caries free children

Abstract

BACKGROUND:

The occurrence and development of caries is a complex process affected by multiple factor.

OBJECTIVE:

The present study was envisaged to evaluate the plaque fluid in caries free children and children with high caries, in order to establish a data set of bacterial secretion proteomics. A non-labeled quantitative technique based on two-dimensional liquid chromatography-series mass spectroscopy was employed to detect plaque fluid. Based on the proteomics data, the database search, data processing and pathway analysis illuminated the function of these proteins, and clarified the role of plaque microecology in caries occurrence and development.

METHODS:

The study enrolled 8 caries free (CF) children, whose decayed-missed-filled surface of teeth is 0 (dmfs = 0), and caries sensitive (CS) children, whose decayed-missed-filled surface of teeth is > 10(dmfs > 10) (3 5 years old) for the smooth tooth plaque and the plaque in the high caries group. The plaque protein was extracted using the unlabeled quantitative technique like liquid chromatography-series mass spectrometry, using DeCyderTM MS Differential Analysis Software (version 1.0, GE Healthcare) that detected and compared the spectra, and quantified the full scanning before series mass spectroscopy. After obtaining all peptides with quantitative information, significantly differential polypeptide molecules were obtained (p< 0.05), and a metabolic pathway analysis was performed.

RESULTS:

We identified 1,804 peptides with quantitative information, including 39 in CF, 30 in CS, and 1,735 similarly expressing peptides. After statistical analysis, 603 statistically different expression peptide data sets were obtained, including 202 high-expressed peptides in Group CF, 33 greater than 1.5 fold peptides, 401 high-expressed in Group CS and 199 greater than 1.5 fold peptide (173 nonredundant proteins).

CONCLUSION:

Our study obtained the largest known dataset of the bacterial secretion protein in children with high caries, and screened the data set of high caries state. 603 peptides were statistically rich in 101 pathways, including glycolysis pyruvate acid metabolism, tricarboxylic acid cycle, pentyl phosphate pathway, fructose mannose metabolism, starch and sucrose metabolism, and ABC transporters.

1.Introduction

The occurrence and development of caries is a complex process affected by multiple factors, and reflects the composition of microorganisms that is often not constant, but undergoes continuous dynamic changes. It also depends on the complexity of the interaction between the bacteria and the host. The functions within the plaque are not performed by a single individual organism, but involve the entire microbial community. However, in the current stomatology research, people’s understanding of the micro-ecology is often based on the single microbial species purely cultivated in the laboratory, or the interaction of several limited species, and the understanding of the microbial community as a whole is far behind the understanding of its individuals.

The emergence of macroproteomics provides a good platform for a comprehensive research on the plaque protein components, but it is equally challenging. The first step of sample preparation, including the complete extraction of the bacterial intracellular and extracellular proteins in the plaque, is one of the major bottlenecks. In the extracellular environment where bacterial cells survive, the plaque fluid is the forefront of the bacteria interaction, host-specific and non-specific immunity, and is relatively easy for the separation and purification process, thereby being one of the ideal models for the research on caries. By analyzing the differences in the protein composition of the plaque in children without caries and those with high caries, the impact of between the plaque and host on the occurrence and development process of caries in children can be more intuitively and accurately explored.

To accomplish this, the study employed the non-labeled quantitative technology based on two-dimensional liquid chromatography-series mass spectrometry to analyze the plaque fluid in children without caries and children with high caries and established a data set of bacterial secretion proteomics. On this basis, using database search, data processing and pathway analysis, it further clarified the role of plaque microecology in the occurrence and development of caries.

2.Materials and methods

2.1Sampling

According to the third version of the caries diagnosis standard of the Basic Methods of WHO Oral Health Survey, 8 children (CF, dmfs = 0) and CS, dmfs > 10 (3 10) were selected respectively, without any oral diseases, systemic health, and no history of medication (including fluorogens) in March, 2020.

The children required no oral hygiene care on the night before sampling, starting from the morning, and 12 h fasting and drinking before sampling. Washing the collection area with sterile saline. Avoid moisture with cotton roll. In CF group, we scraped all the dental plaque of smooth suface of deciduous molar teeth. In CS group, we scraped all the healthy smooth enamel surface [1, 2]. The parents of the child knowingly agreed for the experimental procedure.

2.2Preparation of plaque sample

The plaque was collected in a pre-cooled 0.5 ml centrifuge tube in crushed ice and immediately sent to the laboratory and centrifuged at 4C, 15,000 g for 60 minutes to remove the bacteria, insoluble impurities and other substances, and the supernatant liquid obtained was the plaque fluid [3]. The plaque fluid was carefully transferred into the new EP tube, a protease inhibitor (Inhibitor cocktail complete, Roche) was added, and the concentrate was collected with the Millipore (cutoff: 5 KD) ultrafiltration tube at 4C, 4500 g. Quantitative protein concentration of the centrifugal fluid was done by Bradford (Bio-Rad, USA), and stored at -80C [4, 5].

Figure 1.

Experimental workflow for TMT labeling and analysis: TMT 10-plex labeling was performed for three sets of technical replicates. Each condition was labeled as follows for the three technical replicates: CF (127N, 129N, 130C), HC (128N, 139C, 131). Moreover, equally amount of proteins from all samples were pooled as an internal standard (IS: 126). The labeled fractions were combined and subjected to High-pH Reversed-Phase Fractionation and desalting, followed by separation using liquid chromatography mass spectrometry (LC-MS/MS), and bioinformatics data analysis.

Experimental workflow for TMT labeling and analysis: TMT 10-plex labeling was performed for three sets of technical replicates. Each condition was labeled as follows for the three technical replicates: CF (127N, 129N, 130C), HC (128N, 139C, 131). Moreover, equally amount of proteins from all samples were pooled as an internal standard (IS: 126). The labeled fractions were combined and subjected to High-pH Reversed-Phase Fractionation and desalting, followed by separation using liquid chromatography mass spectrometry (LC-MS/MS), and bioinformatics data analysis.

Figure 2.

Glycolysis/Gluconeogenesis.

Glycolysis/Gluconeogenesis.

Figure 3.

Pyruvate metabolism.

Pyruvate metabolism.

2.3Preparation of enzyme solution

In order to reduce the differences between the individuals, the plaque proteins of the children without caries and children with high caries were mixed in equal amounts, and a sample library was established. CF and CS plaque were divided into three parts..Each protein samples were supplemented with lysis buffer (8 mol/Lurea, 40 mmol/L Tris, 65 mmol/L DTT) to the total volume of 100 μl, and mixed with 1 M DTT at 37C for 2.5 hours. Subsequently, 10 μl 1 M IAA, was added at room temperature in absence of light and the reaction was continued for 40 minutes. After the above treatment, the protein was completely deformed, the disulfide bond opened up. It was then precipitated with a 5 x volume of precooled acetone (-20C) by resting overnight (16 hours) at -20C. Then, the mixture was centrifuged at 14,000 g for 40 minutes; the organic solvent was removed using pre-cooled acetone at -20C, centrifuged again at 14,000 g for 40 minutes. To remove the salt ions, precooled 70% ethanol (-20C) was added and centrifuged at 14,000 g for 40 minutes and then freeze dried. After the enzyme solution was completed, the ultrafiltration membrane was employed with Millipore 10 KD aperture size to collect the filter fluid and freeze dried at -80C.

Figure 4.

Tricarboxylic acid cycle.

Tricarboxylic acid cycle.

Figure 5.

Pentose phosphate pathway.

Pentose phosphate pathway.

Figure 6.

Fructose mannose metabolism.

Fructose mannose metabolism.

2.4Liquid chromatography-mass spectrometry analysis

20 μg of the prepared enzyme solutions were taken and analyzed using the Ettan MDLC liquid chromatography-series mass spectroscopy system (GE Healthcare, Piscataway, NJ, USA). RP trap columns (Zorbax 300 SBC 18, Agilent Technologies, Palo Alto, CA, USA) were employed with an automatic sample feeder. The sample was desalted using the C18 trap column. The sample was separated on the C18 column (Millipore water in A phase and 0.1% FA 84% B finishing water solution, at a gradient rising from 4% to 50% B phase within 2 hours). The separation speed was 2 μl/min. The samples were removed from the column, and subjected directly to electric spray sourceTMLTQTMLinear ion-trap mass spectrometry (Thermo Electron, San Jose, CA, USA). The LTQ mass spectrometry was performed in the automatic gain control (AGC) mode, with the ion source parameters set as: electric spray voltage – 3.2  kV; capillary temperature – 170C. Full-scan mass spectrograms were collected in the profile mode, while MS/MS maps were collected in the centroid mode, with 5 centroid mode scans after each profile mode. The analysis was repeated 3 times per sample.

Figure 7.

Fructose mannose metabolism.

Fructose mannose metabolism.

2.5Database search and data processing

After obtaining all peptides with quantitative information, It was tested for all p< 0.05, and searched with the SEQUEST program (Bioworks Browser Software suite, Thermo Electron, version 3.1) at the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov) based on the genome information of 24 common oral bacteria in Genome. It was downloaded to get the corresponding protein sequence database (24 common oral bacteria including Streptococcus gordonii str. Challis substr. CH1, Streptococcus mutans UA159, Streptococcus sanguinis SK36, Streptococcus salivarius SK126, Actinomyces odontolyticus ATCC 17982, Lactobacillus acidophilus, Lactobacillus fermentum, Neisseria mucosa ATCC 25996, Neisseria sicca ATCC 29256, Neisseria subflava NJ9703, Veillonella dispar ATCC 17748, Veillonella parvula DSM 2008, Corynebacterium matruchotii, Corynebacterium diphtheriae NCTC 13129, Leptotrichia buccalis DSM 1135, Eikenella corrodens ATCC 23834, Porphyromonas gingivalis, Prevotella melaninogenica ATCC 25845, Capnocytophaga gingivalis ATCC 33624, Capnocytophaga ochracea DSM 7271, Capnocytophaga sputigena ATCC 33612, Fusobacterium nucleatum, Treponema denticola ATCC 35405, Campylobacter rectus RM3267). The polypeptide molecules were identified and their corresponding proteins were relatively quantified. The filter parameters were: when Charge + 1, Xcorr 1.9; when Charge + 2, Xcorr 2.2; when Charge + 3, Xcorr 3.75; where DelCN 0.1.

2.6Pathway analysis

The metabolic pathway map was downloaded for the 24 common oral bacteria from the www.kegg.com website to analyze the distribution of the identified proteins in each pathway.

2.7Microbial function and pathway analysis

All identified microbial protein sequences were annotated by BLASTP (version: 2.2.31+) against the UniProtKB/Swiss-Prot database that included 560,118 sequences and the COG database (version: 2014) that included 1,781,653 sequences. Furthermore, InterProScan (version: 5.35–74.0) provided the gene ontology (GO) functional annotations of all identified microbial protein sequences with default parameters. Some in-house Perl scripts and R scripts were used to complete the GO functional classification and statistics analysis. The KEGG orthology (KO) annotation of the proteins were performed using KOBAS (version: 3.0) with E-value1e-05 and rank5. Moreover, KOBAS was also used to perform a binomial test between the two groups in the KEGG pathway levels. Assignment of the proteins in the KEGG pathway levels was then visualized with Krona Excel Template.

2.8PRM verification

Based on the results of the original label-free based quantitative meta-proteomics analysis, we selected the appropriate target peptides of the candidate proteins and performed targeted shotgun MS to finally determine the peptides of the target proteins with reliable identification information, which was used in the PRM quantification analysis. The peptide information suitable for PRM analysis was imported into the Xcalibur software program for PRM setup. Briefly, 1 μg peptide from each sample was taken for LC-PRM/MS analysis. After sample loading, chromatographic separation was performed using a Thermo Scientific EASY-nLC nano-HPLC system. The following buffer was used: A solution was 0.1% formic acid aqueous solution and solution B was a mixed solution of 0.1% formic acid, acetonitrile, and water (95% of acetonitrile). The column was first equilibrated with 95% A solution. The sample was injected into a Trap column (100 μm × 20 mm, 5 μm-C18, Dr. Maisch GmbH) and subjected to gradient separation through a chromatography column (75 μm × 150 mm, 3 μm-C18, Dr. Maisch GmbH) at a flow rate of 250 nL/min. The liquid phase separation gradient was as follows: 0–25 minutes, linear gradient of B liquid from 5% to 18%; 25–45 minutes, linear gradient of B liquid from 18% to 50%; 45–48 minutes, linear gradient of B liquid from 50% to 95%; and 48–60 minutes, B liquid maintained at 95%. The peptides were separated and subjected to targeted PRM/MS using a Q-Exactive mass spectrometer (Thermo Scientific). The analysis time was 60 min. The parameters were set as follows: detection mode – positive; parent ion scanning range – 350–1500 m/z; capillary voltage – 1.8 kv; isolation width – 1.6 Th; first-order MS resolution – 70,000 @m/z 200; AGC target – 3e6; first-level maximum IT – 250 ms. Peptide secondary MS was performed as follows: for each full scan, target peptides of the precursor m/z were sequentially selected based on the inclusion list for second-order MS (MS2) scan with the parameters as follows: resolution – 35,000@m/z 200; AGC target – 3e6; Level 2 Maximum IT – 120 ms; MS2 Activation Type – HCD; Peptide fragmentation – nitrogen; Isolation window – 2.0 Th; Normalized collision energy – 28 eV. The obtained PRM data of the raw RAW file was analyzed using the Skyline 3.5 software program. Statistical analysis was completed with R and the ‘MetaboAnalystR’ package.

Data availability: All the MS raw files were submitted to the Proteome Xchange Consortium (http://www.proteomexchange.com) via the PRIDE partner repository with the data set identifier.

2.9Statistical analysis

Statistical analysis was performed using the SPSS version 19 software. The experiments were statistically analyzed with the independent sample T test. All statistical analysis were performed at 95% significance level using 2-tailed analysis.

Figure 8.

ABC transport proteins.

ABC transport proteins.

Figure 9.

Glycolysis reaction formula.

Glycolysis reaction formula.

Table 1

High expression of bacterial secretory protein in plaque fluid of caries free children (> 1.5 fold)

NUMMass (Da)Av. RatioProteinID Details
12019.22463.9419625gi|34763016Nicotinate-nucleotide pyrophosphorylase
21627.08413.9031119gi|228274697ISPg2, transposase
3844.773333.1448998gi|229211250uncharacterized conserved protein
42015.80372.6245635gi|228277090competence protein
51308.92372.53298gi|197736798hypothetical protein FNP_1346
61485.06292.1089494gi|213962598ribosome recycling factor
71004.83061.965104gi|223039105selenium metabolism protein YedF
81583.10561.9346806gi|229255033predicted extracellular nuclease
91528.02141.9116673gi|229211921peroxiredoxin
101594.87061.8001297gi|229255138outer membrane protein
111369.66391.7949729gi|34763038NADH dehydrogenase reductase
121495.23131.793346gi|188995429hypothetical protein PGN_1565
131328.78011.7567087gi|228275526peptide chain release factor 2
141043.26491.7419186gi|226710238ribosomal protein L15
151289.21591.7255517gi|229210576chaperone protein DnaK
16905.046551.6972979gi|223039140GTP-binding protein TypA/BipA
171814.32221.696517gi|228277158cell division protein FtsA
181341.91641.6860124gi|229210533glutamate dehydrogenase/leucine dehydrogenase
191614.04951.6716142gi|223038584carbamoyl-phosphate synthase, large subunit
201347.16391.6420553gi|42527896Jag protein, putative
211434.18411.6119828gi|229210576chaperone protein DnaK
221440.68991.6006457gi|34762754Alkyl hydroperoxide reductase C22
231583.07561.599004gi|223039559VirB10
241296.96191.5660363gi|229210802glyceraldehyde-3-phosphate dehydrogenase
251414.27791.561902gi|229212600LSU ribosomal protein L15P
261743.67741.5616289gi|2230395523-phosphoshikimate 1-carboxyvinyltransferase
271438.0471.5568823gi|238058718Phosphoserine aminotransfera
28913.142031.5564213gi|229212593LSU ribosomal protein L5P
29714.501161.5434605gi|229254206outer membrane protein
30888.512951.5399202gi|229210548fructose-bisphosphate aldolase
311254.59321.5356884gi|223039512phosphoribosylaminoimidazole carboxylase
321383.49121.5141757gi|223038622protein TolB
331366.12021.5058051gi|213963395putative outer membrane protein

Table 2

High expression of bacterial secretory protein in plaque fluid of high caries children(> 1.5 fold)

NUMMass (Da)Av. ratioProteinID details
12968.5514.07gi|229210864pyruvate kinase
21921.245.88gi|225023847hypothetical protein EIKCOROL_00713
31652.715.62gi|223038968GTP cyclohydrolase II
42016.634.81gi|229211338D-3-phosphoglycerate dehydrogenase
52463.404.80gi|213964012glyceraldehyde-3-phosphate dehydrogenase
62076.894.54gi|229211633bacterial nucleoid protein Hbs
71760.033.97gi|228276851signal transduction sensor histidine kinase
81702.163.60gi|42526786Fe-hydrogenase large subunit family protein
92008.273.29gi|42527800galactokinase, putative
101399.833.16gi|229255924glycosyltransferase
111767.073.14gi|228274481CobN/magnesium chelatase family protein
122283.303.00gi|229210533glutamate dehydrogenase/leucine dehydrogenase
131969.372.96gi|229255585conserved hypothetical protein YmdA/YtgF
142120.522.89gi|229211673aminotransferase [Leptotrichia buccalis DSM 11
151141.802.73gi|42527828cobyric acid synthase CobQ, putative
161420.062.68gi|223039292periplasmic nitrate reductase, large subunit
172206.432.68gi|213962023translation elongation factor Tu
181793.182.60gi|228274858alpha-glucosidase
191989.892.59gi|229212231Ser-tRNA (Thr) hydrolase; threonyl-tRNA synthet
201680.712.55gi|34763824Butyrate-acetoacetate CoA-transferase subunit B
212506.352.55gi|229212304Phospho-N-acetylmuramoyl-pentapeptide-transfer
222490.592.52gi|229212655theronine dehydrogenase-like Zn-dependent dehy
231848.552.52gi|197737364flavoprotein [Fusobacterium nucleatum subsp.
242545.122.45gi|197736680ESS family glutamate:sodium (Na+) symporter
252168.042.41gi|42527533OmpA family protein
261420.072.40gi|229212277galactose-6-phosphate isomerase lacB subunit
272550.842.36gi|229210656PTS system IIA component
282574.222.36gi|229212275tagatose-bisphosphate aldolase
292477.692.35gi|228275593glyceraldehyde-3-phosphate dehydrogenase, type I
302337.252.33gi|228275800translation elongation factor Ts
311390.892.28gi|34763496Transposase
321972.362.27gi|228275746All-trans-retinol 13,14-reductase
331893.572.26gi|42525942bacteriocin ABC transporter, bacteriocin-binding
341683.482.24gi|42528037hypothetical protein TDE2537
352116.252.22gi|197735845heat shock protein HtpG
361961.892.21gi|229211604glycerol dehydrogenase-like oxidoreductase
372130.662.21gi|228274607lysine–tRNA ligase
382056.262.20gi|42525700ABC transporter, ATP-binding protein
391595.092.19gi|197735846fructose-bisphosphate aldolase
401629.072.19gi|229212489Zn-dependent alcohol dehydrogenase
411747.082.18gi|42525562TPR domain-containing protein
422085.762.14gi|188994038probable transcriptional regulator AraC famil
432455.922.13gi|188994275thiol-disulfide interchange protein
441789.442.11gi|2292112242-isopropylmalate synthase
451753.582.11gi|228275128thiol-disulfide isomerase and thioredoxin
461565.072.10gi|229212393PTS system IIC component; diguanylate phosphod
471764.522.09gi|223039902methionine import ATP-binding protein MetN
481865.752.07gi|2282750772,3-bisphosphoglycerate-dependent phosphoglycerate
491873.802.06gi|34762210DNA integration/recombination/invertion protein
501716.112.06gi|19703909putative cytoplasmic protein
511608.732.05gi|228274448ribosomal protein S6
521938.302.04gi|223039930isocitrate dehydrogenase, NADP-dependent
532109.282.04gi|34396499hypothetical protein PG_0355

Table 2, continued

NUMMass (Da)Av. ratioProteinID details
541830.822.03gi|34764184Fructose-bisphosphate aldolase
552032.142.03gi|229211623aspartate semialdehyde dehydrogenase
562093.272.02gi|34763916Phage protein [Fusobacterium nucleatum subsp. v
571721.752.00gi|225024749hypothetical protein EIKCOROL_01635
582060.162.00gi|34762309Aspartate carbamoyltransferase
592051.331.99gi|229210854bacterial nucleoid protein Hbs
601689.001.99gi|225025771hypothetical protein EIKCOROL_02675
612109.081.99gi|213962365GDP-mannose 4,6-dehydratase
621984.141.99gi|229210454hypothetical protein LebuDRAFT_02810
631769.301.99gi|229212758DNA/RNA helicase, superfamily II, SNF2 family
641982.311.98gi|34762754Alkyl hydroperoxide reductase C22
651604.101.97gi|225025378hypothetical protein EIKCOROL_02276
662352.231.96gi|229210734nickel ABC transporter, periplasmic nickel-bin
671801.251.96gi|229211277triosephosphate isomerase
682169.291.94gi|42525820hypothetical protein TDE0304
691956.471.94gi|42528183RNA polymerase sigma factor WhiG
702003.221.92gi|34763262DNA helicase
711580.181.91gi|213962986conserved hypothetical protein
721634.891.90gi|42526801TldD/PmbA family protein
731813.181.89gi|34762500hypothetical protein
741473.491.89gi|229256034CRISPR-associated protein, Csn1 family
751917.001.88gi|225025193hypothetical protein EIKCOROL_02088
761764.271.88gi|229212814SSU ribosomal protein S30P
771695.781.86gi|42525831ABC transporter ATP-binding protein/peptidase
781892.921.86gi|213962338isocitrate dehydrogenase, NADP-dependent
791714.291.86gi|213963684probable transcriptional regulatory protein, C
801484.021.86gi|229211130glycogen/starch/alpha-glucan phosphorylase
811812.441.86gi|228275794conserved hypothetical protein
821759.241.85gi|213962889conserved hypothetical protein
831302.121.85gi|229254579hypothetical protein CochDRAFT_08810
841912.251.85gi|213962806apolipoprotein N-acyltransferase
851840.921.85gi|197735467ABC superfamily ATP binding cassette transpor
862159.331.84gi|42526405ABC transporter, ATP-binding protein
871523.071.83gi|229211940phosphoglycerate kinase
882126.301.83gi|34762663Phosphoglycerate kinase
891890.451.82gi|228275464isoleucine-tRNA ligase
902015.121.82gi|34762786CDP-glucose 4,6-dehydratase
911447.571.82gi|229211563uncharacterized conserved protein
921468.711.82gi|34763070tRNA (Uracil-5-) -methyltransferase
931811.061.82gi|197736083hypothetical protein FNP_0608
941769.041.81gi|223038758outer membrane lipoprotein
952322.331.81gi|225024644hypothetical protein EIKCOROL_01521
961898.961.81gi|34762648GTP-binding protein TypA/BipA TypA/BipA
971754.571.80gi|213963724dihydrolipoyl dehydrogenase
982038.831.80gi|34762615Hypothetical Cytosolic Protein
991804.831.79gi|228276477conserved hypothetical protein
1001720.611.79gi|197735629hypothetical protein FNP_0141
1011255.861.79gi|223039442ATP-dependent DNA helicase RecG
1022159.841.78gi|34764317Flavodoxin
1031949.981.77gi|197736855glutamate formimidoyltransferase
1041735.951.77gi|229210412nonphosphorylating glyceraldehyde-3-phosphate
1051417.961.77gi|19703626DNA polymerase III alpha subunit
1062435.471.76gi|225023733hypothetical protein EIKCOROL_00597

Table 2, continued

NUMMass (Da)Av. ratioProteinID details
1071952.191.76gi|197735760copper (Cu2+)-exporting ATPase
1081946.131.75gi|34762728Enolase
1092044.801.75gi|228275814fructose-bisphosphate aldolase, class II
1102101.111.74gi|225023349hypothetical protein EIKCOROL_00207
1111870.301.73gi|188995942mannose-1-phosphate guanylyltransferase
1121815.151.72gi|228275794conserved hypothetical protein
1132065.651.72gi|229211517sulfite reductase, beta subunit (hemoprotein)
1142144.061.72gi|229210391signal transduction histidine kinase, COG0642
1151444.381.72gi|223038512hypothetical protein CAMRE0001_0295
1161681.921.71gi|188995759hypothetical protein PGN_1895
1171946.321.70gi|229211610uncharacterized paraquat-inducible protein B
1181982.211.70gi|229212544phosphoribosylformylglycinamidine synthase
1191928.051.70gi|213962314hypothetical protein CAPSP0001_0185
1202053.301.69gi|42525700ABC transporter, ATP-binding protein
1211674.501.69gi|229211928Fe-S oxidoreductase
1222025.651.68gi|197737300possible plasmid mobilization protein
1232124.281.67gi|229211402D-isomer specific 2-hydroxyacid dehydrogenase
1242205.301.66gi|213963583conserved hypothetical protein
1251460.651.66gi|42527134glycine cleavage system H protein
1261899.491.66gi|188994568putative tonB-linked outer membrane receptor
1271541.421.66gi|213963481glycogen synthase
1281887.211.64gi|1977369953-dehydroquinate synthase
1291273.981.64gi|228274891conserved hypothetical protein
1301657.531.63gi|197736095pyruvate synthase [Fusobacterium nucleatum su
1311483.781.63gi|229211272hypothetical protein LebuDRAFT_11420
1322134.601.62gi|228276496ribosomal protein S3
1331618.981.62gi|197736759N-acyl-D-aspartate/D-glutamate deacylase
1341782.111.61gi|34397232DNA-binding protein, histone-like family
1351586.321.61gi|42526652phage minor structural protein, putative
1361693.941.61gi|197736825hypothetical protein FNP_1373 [Fusobacterium
1372148.121.61gi|197735216elongation factor EF1A
1382002.161.61gi|225025671hypothetical protein EIKCOROL_02573
1391480.441.60gi|188994351FtsK/SpoIIIE family cell division protein
1401816.961.60gi|19703982putative cytoplasmic protein
1411776.341.59gi|42527210hypothetical protein TDE1704
1422021.761.59gi|42526714integrase/recombinase XerD
1432098.431.59gi|225024872hypothetical protein EIKCOROL_01760
1441480.961.58gi|213964056aspartyl-tRNA synthetase
1451712.681.57gi|213962204hypothetical protein CAPSP0001_1551
1461874.391.57gi|225023233hypothetical protein EIKCOROL_00085
1471494.211.57gi|229210434UDP-N-acetylmuramyl tripeptide synthase
1481673.821.56gi|197052724-amino-4-deoxychorismate lyase
1491951.211.56gi|42525731TPR domain-containing protein
1502204.991.56gi|228274869chaperone protein DnaK
1511590.111.56gi|188993943hypothetical protein PGN_0079
1521601.161.56gi|42527320hypothetical protein TDE1814
1531889.491.56gi|42528104hypothetical protein TDE2604
1541664.981.55gi|223039847fructose-1,6-bisphosphatase
1551377.941.55gi|34764886Export ABC transporter
1562059.941.55gi|34762866hypothetical protein
1572792.721.55gi|229212597LSU ribosomal protein L18P [Leptotrichia bucca
1581143.011.55gi|229212654hypothetical protein LebuDRAFT_25250
1591772.951.54gi|228276146hypothetical protein CAPGI0001_0708
1601601.401.54gi|188995090ribonucleotide reductase

Table 2, continued

NUMMass (Da)Av. ratioProteinID details
1611885.911.54gi|42527008hypothetical protein TDE1500
1621999.211.54gi|42527772methyl-accepting chemotaxis protein
1631859.621.54gi|229212449McrBC 5-methylcytosine restriction system comp
1641423.171.53gi|229255650hypothetical protein CochDRAFT_19730
1652024.661.53gi|229210424alpha-phosphoglucomutase
1661603.161.53gi|213963535conserved hypothetical protein
1672136.531.52gi|197736694hypothetical protein FNP_1239
1682170.121.52gi|213962656conserved hypothetical protein
1691958.171.52gi|225023180hypothetical protein EIKCOROL_00032
1701441.731.52gi|229255214protease subunit of ATP-dependent protease
1711786.801.51gi|18463955replication protein
1721655.441.51gi|42526889V-type ATP synthase subunit E
1731460.621.51gi|34762313Carbamoyl-phosphate synthase large chain

3.Results

3.1Label-free 2D-LC-MS/MS Identification

Liquid chromatography-series mass were analyzed in CF, CS group (we repeated the experiments for three times), including 1804 quantitative information peptides, 39 in CF group, and 30 in CS group. The data from liquid chromatography-series mass spectroscopy was analyzed by DecyderMS software, and 603 peptide data sets were obtained, including 202 in CF group. Among them, 33 peptide has a much higher significant differences which was greater than 1.5 times (Table 1), On the other hand, we found 401 peptide in CS group. And there were 199 among them has a greater differences which more than 1.5 times (173 without redundant proteins, Table 2).

3.2Gene ontology function analysis

In total, 9194 (80.16%) identified microbial leading proteins corresponded to at least one GO term using InterProScan and in-house Perl Scripts. The number of proteins was counted at GO level 2 of biological process, cellular component, and molecular function ontology, respectively (Fig. 7). Moreover, the proteins of two groups that corresponded to the GO term of biological process, cellular component, and molecular function ontology were counted. Then, Fisher’s exact test was performed to compare the difference of the protein group number between the two groups. Based on a p< 0.05 level, the GO terms with CS group included 35 in biological process ontology, 2 in cellular component, and 30 in molecular function ontology. The GO terms with CF group included 59 in biological process ontology, 17 in cellular component, and 30 in molecular function ontology (Fig. 8).

The count of proteins corresponding to GO terms of all samples were performed using in-house Perl and R scripts. With a p< 0.05, 80 GO terms (33 in biological process ontology, 5 in cellular component ontology, and 42 in molecular function ontology) were found in atleast12 pair samples with high caries, while only 10 GO terms (8 in biological process ontology and 2 in molecular function ontology) were found in the caries-free specimen. Then, we transformed the p-value with negative log10, and visualized them with heatmaps using R (Fig. 9).

3.3PRM verification

Parallel reaction monitoring (PRM) mass spectrometry was used to verify the target peptides determined by the metaproteomic analysis and a pre-experiment, and the 171 candidate peptides of the target protein were subjected to LC-PRM/MS analysis. In total, 103 candidate proteins were quantified by LC-PRM/MS, including 3 proteins (hinf_c_1_1270, fnuc2539_c_1_361, cgin_c_10_1771) that were determined as the differential expressed protein candidates in the metaprotemics study. The Skyline analysis results of each candidate peptide were shown.

Meanwhile, 17 differential expressed peptide candidates were confirmed by the Mann-Whitney U test with a p< 0.05 cutoff, 15 differential expressed peptide candidates were obtained by paired-samples T test with a p< 0.05 cutoff, and 7 peptides in common (Table 6).

Figure 10.

Glycolysis.

Glycolysis.

Figure 11.

Gluconeogenesis.

Gluconeogenesis.

Table 3

High expression ABC transporter data set of CS group (P< 0.05)

NumRatioGI IDID details
12.26gi|42525942bacteriocin ABC transporter, bacteriocin-binding
22.20gi|42525700ABC transporter, ATP-binding protein
31.96gi|229210734nickel ABC transporter
41.86gi|42525831ABC transporter ATP-binding protein/ peptidase
51.85gi|197735467ABC superfamily ATP binding cassette transporter
61.84gi|42526405ABC transporter, ATP-binding protein
71.69gi|42525700ABC transporter, ATP-binding protein
81.55gi|34764886Export ABC transporter
91.44gi|197735439ABC superfamily ATP binding cassette transpor
101.37gi|34763755ABC transporter ATP-binding protein
111.39gi|229211590ABC-type metal ion transport system
121.19gi|34763045ABC superfamily ATP binding cassette transpor
131.12gi|34763548Hemin transport system ATP-binding protein hmuV

Table 4

High expression ABC transporter data set of CF group (P< 0.05)

NumRatioGI IDID details
11.32gi|229210852ABC-type uncharacterized transport system
21.26gi|188994222putative ABC transporter ATP-binding protein
31.18gi|42525832ABC transporter, ATP-binding/permease protein
41.16gi|34763794.1branched chain amino acid ABC superfamily ATP

4.Discussion

In this study, we initially used the method of macroproteomics to find the bacterial secretion proteins in caries-free children and children with high caries, with a total of 1735 peptides, including 603 statistically different peptides. Further bioinformatics study found that the proteins with differences in the expression were more than 1.5 times mainly concentrated in the glycolysis/glyneogenesis, pyruvate metabolism, citric acid circulation, ABC transporters, etc. We will discuss from two aspects – the pathways and the key proteins.

4.1Saccharolysis/sugar lyiogenesis

4.1.1Glycolysis

Saccharolysis (glycolysis) is the first step in the sugar metabolism process of all biological cells. During this process, a molecule of glucose undergoes a ten-step enzyme reaction to form two molecules of pyruvate with the formation of ATP (Figs 810). This suggests the presence of active sugar metabolism in the caries-causing plaque, presumably due to the highly expressed enzymes that use intracellular polysaccharide, mainly glycogen as a source of energy, resulting in tooth demineralization [6].

Phosphorylation of the phosphoric fructose (phosphorylation of fructose-6-phosphate) is the third step of glycolysis, further phosphorylation of C on 6-phosphate fructose initially produces 1,6-diphosphate fructose supplied by ATP. The reaction is catalyzed by phosphate fructose kinase (phosphofructokinase, PFK), which is an important speed limiting enzyme in the sugar aerobic oxidation process. Phosphoric transfer of phosphoenol pyruvate is the final reaction in glycolysis that involves the transfer of the high energy phosphorate group from phosphoroll pyruvate to ADP, and is catalyzed by pyruvate kinase, PK, which is another phosphorylation process at the substrate level.

Figure 12.

Tricarboxylic acid.

Tricarboxylic acid.

Table 5

Co expression ABC transporter data set of CS&CF group (P> 0.05)

NumGI IDID details
1gi|197735467ABC superfamily ATP binding cassette transport
2gi|229212097ABC-type multidrug transport system
3gi|229212809ABC-type multidrug transport system
4gi|229210643ABC-type oligopeptide transport system
5gi|42527941ABC transporter, ATP-binding/permease protein
6gi|229211946ABC-type cobalt transport system
7gi|229211911ABC-type Fe3+ transport system
8gi|229211590ABC-type metal ion transport system
9gi|42526433ABC transporter, ATP-binding/permease protein
10gi|42528282ABC transporter, ATP-binding/permease protein
11gi|42525789ABC transporter, ATP-binding/permease protein
12gi|42526418ABC transporter, ATP-binding protein
13gi|42526693ABC transporter, ATP-binding protein
14gi|42525831ABC transporter ATP-binding protein/peptidase
15gi|229210567amino acid/amide ABC transporter membrane prot
16gi|19704374branched chain amino acid ABC transporter
17gi|197736157dipeptide/oligopeptide/nickel (Ni)2+ ABC supe
18gi|228274621excinuclease ABC subunit A
19gi|42526877excinuclease ABC subunit B
20gi|42527978excinuclease ABC, C subunit
21gi|42527718galactoside ABC transporter, ATP-binding protein
22gi|197736905iron (Fe)3+ ABC superfamily ATP binding casse
23gi|42526259iron compound ABC transporter
24gi|42526690iron compound ABC transporter
25gi|197736077nickel (Ni)2+ ABC superfamily ATP binding cas
26gi|197736393possible nitrate/sulfonate/bicarbonate ABC su

Table 6

Candidate differential expressed peptides were confirmed by Mann-Whitney U test and paired-samples T test in common

Peptide sequencep-value with Mann-Whitney U testp-value with paired-sample T testFold change
VVEYVEKPVIVYR4.90E-024.63E-028.51
YSFSTCYNSER3.56E-034.40E-035.21
TAALENAAEGGFNKK2.19E-025.22E-034.33
VVVEVLSQGK2.27E-025.87E-033.73
LNNCPTSPR4.35E-023.32E-023.71
VLDELTALR4.97E-024.18E-022.50
SPEEAYEHAK4.91E-022.51E-022.14

Figure 13.

A bar chart of protein count at GO level 2 of biological process, cellular component, and molecular function ontology using the ‘ggplot2’ package. The number markers at the bar were protein count of the GO term.

A bar chart of protein count at GO level 2 of biological process, cellular component, and molecular function ontology using the ‘ggplot2’ package. The number markers at the bar were protein count of the GO term.

Reversible reactions in glycolysis include 7 steps: glucose phosphate isomerase is involved in the second step; heterogeneous reaction of glucose phosphate (isomerization of glucose-6-phosphate); participation in step 4 1.6-diphosphate pyrolysis reaction (i.e. cleavage of fructose 1, 6 di/bis phosphate from fructose-1, 6-Bisphosphate Aldoase (fructose-1, 6-bisphosphate aldolase); participation in step 6: 3-glyceraldehyde phosphate oxidation reaction (oxidation of glyceraldehydes-3-phosphate); 3-glyceraldehyde phosphate dehydrogenase (glyceraldehyde 3-phosphate dehydrogenase); phosphorate kinase (phosphoglycerate kinase, PGK) participating in high energy phosphate bond transfer of step 1.3-diphosphate glyceric acid. These enzymes showed a high expression in the plaque fluid in both two groups. Studies show that the above catalytic enzymes participate in the sugar heterogeneous reaction at the same time. So, we speculate that both in caries-free or caries causogenic plaque, the glycolysis and sugar heterogeneous reaction can be accurately adjusted, so that the bacteria in the plaque can use the excess sugar in the form of glycogen as energy storage to meet their own energy needs.

The final reversible reaction is step 2-phosphoglyceric acid, catalyzed by enolase, which was highly expressed in the CS group (P< 0.05, ratio = 1.75), and mainly corresponds to the bacterial glycolysis pathway, suggesting that glycololysis plays an extremely important role in carie.

4.1.2Gluconeogenesis and NAD+ regeneration

There are three-step reactions in glycolysis that are irreversible reactions that must be bypassed during sugar heterogenesis, at the cost of higher energy consumption (Fig. 11). The fructose-1,6-diphosphatase involved in this process was highly expressed in the CS group and the phosphoenlate-type pyruvate carboxylated kinase was expressed in both groups, suggesting that the sugar heterogenesis occured in both the mature and the pathogenic plaque and was precisely regulated.

NAD+ can be regenerated by lactate dehydrogenase (lactate dehydrogenase, LDH), ethanol dehydrogenase (Alcohol dehydrogenase, ADH), and NADH dehydrogenase. LDH is the key enzyme for synthetic lactic acid, and its biological effect is the key link in causing caries. S. mutans lacking LDH activity significantly reduced the caries in vivo in the restricted rodent model experiments [7, 8, 9]. However, there was no significant difference in the mean LDH activity of S. mutans in different caries-sensitive populations [10]. This experiment also found no significant difference in the LDH expression in children with no or high caries. But the lack of LDH has a lethal effect on the bacteria, since an LDH deficient strain results in intracellular NAD during aerobic growth+/NADH metabolic imbalance and accumulation of glycolysis toxic intermediates, killing the bacteria. The results of this experiment in turn confirms the idea that, whether there is caries or the absence of caries, there must be an active expression of LDH, which is one of the necessary conditions for the Streptococcus bacteria to survive.

4.2Tricarboxylic acid circulation

The cytoplasm of prokaryotes is the site of tricarboxylic acid circulation, but most enzymes are found in plaque fluid, including isocitrate dehydrogenase (isocitrate dehydrogenase, IDH) (Fig. 12), succinate dehydrogenase, malate dehydrogenase, succinyl-assisted A synthase, and α-ketovaltarate dehydrogenase complex in the CS group are unknown.

The IDH superfamily is ancient and large, widespread in the three boundaries of life (archaea, bacteria and eukaryotes). IDH catalyzes isocitric acid to α-ketopenta in tricarboxylic acid (TCA) cycle, bringing NAD+ or the NADP+ to NADH or a NADPH. It not only plays an important role in energy metabolism, amino acids and vitamin synthesis, but also plays a key regulatory role in the TCA circulation and the carbon flux distribution of acid bypass [11, 12, 13, 14].

4.3ABC transporter protein

This study identified more than 50 corresponding adenosine triphosphate binding box transporters (ATP-binding cassette transporter, ABC transporters) in children who were caries-free or with high caries. Associated with the transport of iron, nickel, cobalt ions, iron compounds, metal ions, oligopeptides, dipeptides, amino acids, branched chain amino acids, lactosidase, it is seen that ABC transporters are involved in various physiological functions of bacteria. It is worth noting that we identified 13 highly-expressed ABC transporters in the CS group, 6 proteins expressed more than 1.5 times, while only 4 ABC transporters were highly expressed in the CF group and all were less than 1.5 times, suggesting that material transformation in the process of caries-causing transformation of bacteria. Among them, ABC transporter of the group CS was expressed 2.6 times high, which may be the potential target molecule for caries activity evaluation.

4.4Molecular partner

This experiment identified 34 molecular companion peptide segments, belonging to the Hsp60 (GroEL) family, Hsp70 (DnaK) family, Hsp90 (Http pG) family, and Hspl00 (CIp) family. GroEL’s E. coli is a homologous oligomer complex that plays an important role in the correct folding and assembly of newborn proteins and the recovery of degenerative proteins under thermal or chemical adversity. Although it has been determined that GroEL is located in the cytoplasm, the surface of some pathogens can express GroEL, and this is generally associated with the role the molecular partners play during adhesion [15]. GroEL expression was also detected in plaque fluid. It is speculated that the Hsp molecular companion, as the main antigen of most pathogens, may cause GroEL rearrangement on the bacterial cell membrane in the process of bacterial infection or under stress stimulation. Unlike the first two HSP, we found that HtpG was significantly upregulated in the CS group, but relevant studies showed that HSP90 synthesis speed and synthesis volume after stress were not significantly different than the above HSP, so its mechanism of cell protection needs to be further clarified.

4.5Phosphorylation modification

In this experiment, the presence of two-component systems and Phosphotransferase system (PTS) was detected and consistently increased in expression in group CS, suggesting active protein phosphorylation modification and intercellular signaling in pathogenic biofilms.

The PTS system usually consists of five proteins including the enzyme I, enzyme (including three subunits of A, B and C) and phosphoolenol pyruvate (phosphoenolpyruvate, HPr). High expression of PTS system IIA, IIC in the CS group was also observed in this trial, indicating that the glucose intake within the flora was active during the occurrence of caries and development.

4.6Bacterial phages

At present, specific phages for bacteria such as Actinomyces, Actinobacillus Actinomycetecomitans, Actinomyces viscosus, Enterococcus faecalis (Actinomyces Actinobacillus actinomycetecomitans, Actinomyces viscosus, Enterococcus faecalis have been isolated in plaque and saliva respectively, In this experiment, eight phage-related proteins were detected in two groups, two of them (phages and microstructural proteins) were highly expressed in the high caries group. Although less data on this finding is available, some scholars have speculated on the potential prospect of bacteriophages in the caries prevention and treatment process [16, 17, 18, 19]. Taking a phage as a plaque control method may be a new area.

4.7Membrane protein

The outer membrane is the contact surface of the bacteria and the external environment, and its main components are lipid, lipoprotein and outer membrane protein. Outer membrane protein is the main component of the outer membrane, which plays an important role in material transport, information identification, cell adsorption, and outer membrane protein and secreted protein are also the first choice protein of vaccine antigens. A variety of high-expression of bacterial outer membrane protein, lipoprotein, and apolipoprotein were detected in this experiment, but its function in the occurrence and development of caries needs yet to be studied specifically.

4.8Other key proteins

After PRM verification, we found some key proteins which may play an important role during the development of dental caries in children (Fig. 13), which are discussed below.

Our experimental results show that although PFK and PK are highly expressed in both CF, CS groups, it exceeds 1.5 times in the CS group, indicating that PEK and PK play an important role in the occurrence and development of caries, especially in bacterial caries, and also shows that the glycolysis process can provide energy for the life activity of bacterial cells and maintain the bacterial physiological function in mature plaque.

In addition, this experiment also found that glycan phosphate isomerase was highly expressed in the plaque fluid in children with high caries, indicating that this enzyme may play an important role in the plaque caries-causing process by promoting the effective energy generation of the plaque bacteria.

ADH is a zinc-containing metallicase widespread in human and animal liver, plant and microbial cells, with a broad substrate specificity to convert pyruvate produced by glycolysis into acetaldehyde and NAD and NAD+, thereby generating the energy needed for glycolysis. In this experiment, we found that ADH was highly expressed in the high caries group. It remains to be further studied, whether it also plays a role in the caries-induced transformation of plaque and the information exchange between bacteria.

Hydrohydrogenase (hydrogenase) is an important class of biological enzymes present in the microorganisms that catalyze the oxidation of hydrogen or hydrogen production from reduced protons. In our experimental results, the presence of iron hydrogenase and ferroxygen reduction protein was detected in both groups and significantly highly expressed in the high caries group, presuming that this may be one of the mechanisms where acid-producing and acid-resistant bacteria survive in the acid-induced plaque.

In conclusion, in the present study, we obtained 1804 peptides with quantitative information, including 395 in CF group, 30 in CS group, 1735 peptides in both the groups. The DeCyderTMMS software conducted further statistics and analysis, and obtained 603 data sets of different peptide expression. The function of 391 peptides was unknown in this experimental dataset, and 47 peptides were highly expressed in the high caries group. Their specific function and their relationship with the caries are still uncertain. Nevertheless, macroproteomics, secretory proteomics and bioinformatics analysis has still provided a very good platform for our research, so that we could conduct a good comprehensive analysis of the proteins known to-date. Further research will be conducive to clarify the cause, and looking for disease-related biomarkers, which will be one of our future research directions.

Acknowledgments

This work is supported by the Shanghai Natural Science Foundation of China (grant number: 18zr1422300), the Innovative research team of high-level local universities in Shanghai (SSMU-ZDCX20180901), the Fundamental research program funding of Ninth People’s Hospital affiliated to Shanghai Jiao Tong university School of Medicine (JYZZ139), and the Natural Science Foundation of Tibet Autonomous Region (XZ2019ZR-ZY43(Z)).

Conflict of interest

None to report.

References

[1] 

Corby PM, Lyons-Weiler J, Bretz WA, et al. Microbial risk indicators of early childhood caries. J Clin Microbiol. (2005) ; 43: : 5753-5759.

[2] 

Li Y, Ge Y, Saxena D, Caufield PW. Genetic profiling of the oral microbiota associated with severe early-childhood caries. J Clin Microbiol. (2007) ; 45: : 81-87.

[3] 

Lin Y, Qiu L, Gao X. Relationship between protein components in saliva and plaque fluid and caries susceptibility. Chinese Journal of Stomatology. (2002) ; 37: : 39-42.

[4] 

Yao Y, Grogan J, Zehnder M, et al. Compositional analysis of human acquired enamel pellicle by mass spectrometry. Arch Oral Biol. (2001) ; 46: : 293-303.

[5] 

Yao Y, Berg EA, Costello CE, et al. Identification of protein components in human acquired enamel pellicle and whole saliva using novel proteomics approaches. J Biol Chem. (2003) ; 278: : 5300-5308.

[6] 

Liu Z. Oral biology. People’s Health Publishing Company. Third edition.

[7] 

Hillman JD, Brooks TA, Michalek, et al. Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries. Infect Immun. (2000) ; 68: : 543-549.

[8] 

Fitzgerald RJ, Adams BO, Sandham HJ, et al. Cariogenicity of a Lactate dehydrogenase-deficient mutant of Streptococcus mutans serotype c in gnotobiotic rats. Infect Immun. (1989) ; 57: : 823-826.

[9] 

Hillman JD. Lactate dehydrogenase mutants of Streptococcus mutans: isolation and preliminary characterization. Infect Immun. (1978) ; 21: : 206-212.

[10] 

Yang D, Liu T, Zhou X, et al. Preliminary study on LDH activity of Streptococcus mutans isolates from different caries sensitive populations. West China Journal of Stomatology. (2005) ; 23: : 116-118.

[11] 

Zhu GP, Golding GB, Dean AM. The selective cause of an ancient adaptation. Science. (2005) ; 307: : 1279-1282.

[12] 

Lunzer M, Mill ER SP, Felsheim R. The biochemical architecture of an ancient adaptive landscape. Science. (2005) ; 310: : 499-501.

[13] 

Ell-ington AD, Bull JJ. Changing the cofactor diet of an enzyme. Science. (2005) ; 310: : 454-455.

[14] 

Jung IL, Kim SK, Kim IG. The RpoS-mediated regulation of isocitrate dehydrogenase gene expression in Escherichia coli. Curr Microbiol. (2006) ; 52: : 21-26.

[15] 

Garduno RA, Garduno E, Hoffman PS. Surface-associated hsp60 chaperonin of Legionella pneumophila mediates invasion in a HeLa cell model. Infect Immun. (1998) ; 66: : 4602-4610.

[16] 

Delisle AL, Nauman RK, Minah GE. Isolation of a bacteriophage for Actinomyces viscosus. Infection and Immunity. (1978) ; 20: : 303-306.

[17] 

Tylenda CA, Calvert C, Kolenbrander PE, Tylenda A. Isolation of Actinomyces bacteriophage from human dental plaque. Infection and Immunit. (1985) ; 49: : 1-6.

[18] 

Yeung MK, Kozelsky CS. Transfection of Actinomyces spp. by genomic DNA of bacteriophages from human dental plaque. Plasmid. (1997) ; 37: : 141-153.

[19] 

Bachrach G, Leizerovici-Zigmond M, Zlotkin A, Naor R, Steinberg D. Bacteriophage isolation from human saliva. Lett Appl Microbiol. (2003) ; 36: : 50-3.